Cu-64 DOTATATE ( DrugBank: Dotatate )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 84 | Sarcoidosis | 1 |
84. Sarcoidosis
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02812849 (ClinicalTrials.gov) | June 2016 | 22/6/2016 | Somatostatin Receptor Imaging in Cardiac Sarcoidosis | Somatostatin Receptor Imaging in Cardiac Sarcoidosis | Cardiac Sarcoidosis | Drug: Cu-64 DOTATATE | Rigshospitalet, Denmark | NULL | Withdrawn | 18 Years | N/A | All | 0 | Denmark |